Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 1910852, 8 pages
http://dx.doi.org/10.1155/2016/1910852
Clinical Study

HLA-01:03 Allele in Lung Transplant Recipients Correlates with Higher Chronic Lung Allograft Dysfunction Occurrence

1CNRS, EFS, ADES UMR 7268, Aix-Marseille Université, 13916 Marseille, France
2Immunogenetics Laboratory, EFS-Alpes Méditerranée, 13005 Marseille, France
3Department of Public Health, EA 3279 Research Unit, Marseille University Hospital, Aix-Marseille University, Marseille, France
4Service de Pneumologie, Hôpital Nord, 13015 Marseille, France
5Service de Chirurgie Thoracique, Hôpital Nord, 13015 Marseille, France

Received 30 March 2016; Revised 8 May 2016; Accepted 19 May 2016

Academic Editor: Fabio Morandi

Copyright © 2016 Julie Di Cristofaro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. Yusen, J. D. Christie, L. B. Edwards et al., “The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report—2013; focus theme: age,” Journal of Heart and Lung Transplantation, vol. 32, no. 10, pp. 965–978, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. G. M. Verleden, G. Raghu, K. C. Meyer, A. R. Glanville, and P. Corris, “A new classification system for chronic lung allograft dysfunction,” Journal of Heart and Lung Transplantation, vol. 33, no. 2, pp. 127–133, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. M. Verleden, R. Vos, B. Vanaudenaerde et al., “Current views on chronic rejection after lung transplantation,” Transplant International, vol. 28, no. 10, pp. 1131–1139, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Di Cristofaro, M. Reynaud-Gaubert, F. Carlini et al., “HLA-G01:04∼UTR3 recipient correlates with lower survival and higher frequency of chronic rejection after lung transplantation,” American Journal of Transplantation, vol. 15, no. 9, pp. 2413–2420, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. V. M. Braud, D. S. J. Allan, C. A. O'Callaghan et al., “HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C,” Nature, vol. 391, no. 6669, pp. 795–799, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Pietra, C. Romagnani, M. Falco et al., “The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition,” European Journal of Immunology, vol. 31, no. 12, pp. 3687–3693, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Heinrichs and H. T. Orr, “HLA non-A,B,C class I genes: their structure and expression,” Immunologic Research, vol. 9, no. 4, pp. 265–274, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Lee, M. Llano, M. Carretero et al., “HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 5199–5204, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Michaëlsson, C. Teixeira de Matos, A. Achour, L. L. Lanier, K. Kärre, and K. Söderström, “A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition,” Journal of Experimental Medicine, vol. 196, no. 11, pp. 1403–1414, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Kochan, D. Escors, K. Breckpot, and D. Guerrero-Setas, “Role of non-classical MHC class I molecules in cancer immunosuppression,” OncoImmunology, vol. 2, no. 11, Article ID e26491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. D. C. Julie, S. Buhler, C. Frassati et al., “Linkage disequilibrium between HLA-G0104 and HLA-E0103 alleles in Tswa Pygmies,” Tissue Antigens, vol. 77, no. 3, pp. 193–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Antoun, S. Jobson, M. Cook, P. Moss, and D. Briggs, “Ethnic variability in human leukocyte antigen-E haplotypes,” Tissue Antigens, vol. 73, no. 1, pp. 39–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Carvalho dos Santos, L. V. Tureck, P. F. Wowk et al., “HLA-E polymorphisms in an Afro-descendant Southern Brazilian population,” Human Immunology, vol. 74, no. 2, pp. 199–202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. C. Castelli, C. T. Mendes-Junior, A. Sabbagh et al., “HLA-E coding and 3' untranslated region variability determined by next-generation sequencing in two West-African population samples,” Human Immunology, vol. 76, no. 12, pp. 945–953, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. L. C. Sullivan, C. S. Clements, J. Rossjohn, and A. G. Brooks, “The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity,” Tissue Antigens, vol. 72, no. 5, pp. 415–424, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Tamouza, V. Rocha, M. Busson et al., “Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation,” Transplantation, vol. 80, no. 1, pp. 140–144, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Tamouza, M. Busson, V. Rocha et al., “Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation,” Transplantation, vol. 82, no. 11, pp. 1436–1440, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Danzer, H. Polin, J. Pröll et al., “Clinical significance of HLA-E0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation,” Transplantation, vol. 88, no. 4, pp. 528–532, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Hosseini, A. P. Schwarer, A. Jalali, and M. Ghasemzadeh, “The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation,” Leukemia Research, vol. 37, no. 5, pp. 516–519, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Wieten, N. M. Mahaweni, C. E. M. Voorter, G. M. J. Bos, and M. G. J. Tilanus, “Clinical and immunological significance of HLA-E in stem cell transplantation and cancer,” Tissue Antigens, vol. 84, no. 6, pp. 523–535, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ulbrecht, S. Martinozzi, M. Grzeschik et al., “Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis,” The Journal of Immunology, vol. 164, no. 10, pp. 5019–5022, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Pietra, C. Romagnani, P. Mazzarino et al., “HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 19, pp. 10896–10901, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Allard, P. Tonnerre, S. Nedellec et al., “HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation,” PLoS ONE, vol. 7, no. 11, article e50951, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Pacasova, S. Martinozzi, H.-J. Boulouis et al., “Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice,” The Journal of Immunology, vol. 162, no. 9, pp. 5190–5196, 1999. View at Google Scholar · View at Scopus
  25. M. H. Ravindranath, T. Pham, M. Ozawa, and P. I. Terasaki, “Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients,” International Immunology, vol. 24, no. 1, pp. 43–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Nunes, Generate: Tools for Analysis and Handling of Data with Ambiguities, Laboratory of Anthropology, Genetics and Peopling History, University of Geneva, Geneva, Switzerland, 2006, http://geneva.unige.ch/generate/.
  27. N. Lauterbach, L. Wieten, H. E. Popeijus et al., “Peptide-induced HLA-E expression in human PBMCs is dependent on peptide sequence and the HLA-E genotype,” Tissue Antigens, vol. 85, no. 4, pp. 242–251, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Pabón, C. E. Navarro, J. C. Osorio et al., “Impact of human leukocyte antigen molecules E, F, and G on the outcome of transplantation,” Transplantation Proceedings, vol. 46, no. 9, pp. 2957–2965, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Llano, N. Lee, F. Navarro et al., “HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer,” European Journal of Immunology, vol. 28, no. 9, pp. 2854–2863, 1998. View at Google Scholar · View at Scopus
  30. T. Martinu, D.-F. Chen, and S. M. Palmer, “Acute rejection and humoral sensitization in lung transplant recipients,” Proceedings of the American Thoracic Society, vol. 6, no. 1, pp. 54–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. P. Westall, A. Michaelides, T. J. Williams, G. I. Snell, and T. C. Kotsimbos, “Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation,” Transplantation, vol. 75, no. 12, pp. 2064–2068, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. B. Bigley, K. Rezvani, N. Shah et al., “Latent CMV infection enhances anti-tumor cytotoxicity through accumulation of NKG2C+ NK-cells in healthy humans,” Clinical & Experimental Immunology, 2016. View at Publisher · View at Google Scholar
  33. L. C. Sullivan, G. P. Westall, J. M. L. Widjaja et al., “The presence of HLA-E-restricted, CMV-specific CD8+ T cells in the blood of lung transplant recipients correlates with chronic allograft rejection,” PLoS ONE, vol. 10, no. 8, Article ID e0135972, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Romagnani, G. Pietra, M. Falco et al., “Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 17, pp. 11328–11333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. T. A. W. Holderried, P. A. Lang, H.-J. Kim, and H. Cantor, “Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 52, pp. 21089–21094, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. R. A. Vilchez, J. Dauber, and S. Kusne, “Infectious etiology of bronchiolitis obliterans: the respiratory viruses connection—myth or reality?” American Journal of Transplantation, vol. 3, no. 3, pp. 245–249, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Hosseini, A. P. Schwarer, and M. Ghasemzadeh, “Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?” Experimental Hematology, vol. 43, no. 3, pp. 149–157, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. D. E. Geraghty, M. Stockschleader, A. Ishitani, and J. A. Hansen, “Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism,” Human Immunology, vol. 33, no. 3, pp. 174–184, 1992. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Grimsley and C. Ober, “Population genetic studies of HLA-E: evidence for selection,” Human Immunology, vol. 52, no. 1, pp. 33–40, 1997. View at Publisher · View at Google Scholar · View at Scopus